Characterization of intracellular Ph control in Barrett's oesophagus: Evidence for an adaptive cellular response to gastro-oesophageal reflux

被引：0
|
作者：
Fitzgerald, RC
Farthing, MJG
Triadafilopoulos, G
机构：
[1] St Bartholomews & Royal London Sch Med, Digest Dis Res Ctr, London E1 2AD, England
[2] Stanford Univ Hosp, Stanford, CA 94305 USA
来源：
GUT | 2000年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
W104
引用
收藏
页码：A58 / A58
页数：1
相关论文
共 50 条
  • [21] Normalization of oesophageal pH does not guarantee control of duodenogastro-oesophageal reflux in Barrett's oesophagus
    Todd, JA
    Basu, KK
    de Caestecker, JS
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (08) : 969 - 975
  • [22] Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett's oesophagus
    Fock, Kwong Ming
    Talley, Nicholas
    Goh, Khean Lee
    Sugano, Kentaro
    Katelaris, Peter
    Holtmann, Gerald
    Pandolfino, John E.
    Sharma, Prateek
    Ang, Tiing Leong
    Hongo, Michio
    Wu, Justin
    Chen, Minhu
    Choi, Myung-Gyu
    Law, Ngai Moh
    Sheu, Bor-Shyang
    Zhang, Jun
    Ho, Khek Yu
    Sollano, Jose
    Rani, Abdul Aziz
    Kositchaiwat, Chomsri
    Bhatia, Shobna
    GUT, 2016, 65 (09) : 1402 - +
  • [23] The use of acid-decreasing medication in veteran patients with gastro-oesophageal reflux disorder with and without Barrett's oesophagus
    El-Serag, H. B.
    Wieman, M.
    Richardson, P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (12) : 1293 - 1299
  • [24] Systmatic review with meta-analysis: Risk factors for Barrett's oesophagus in individuals with gastro-oesophageal reflux symptoms
    Eusebi, Leonardo H.
    Telese, Andrea
    Cirota, Giovanna G.
    Haidry, Rehan
    Zagari, Rocco M.
    Bazzoli, Franco
    Ford, Alexander C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (09) : 968 - 976
  • [25] Gastro-oesophageal reflux disease: symptoms, erosions, and Barrett's - what is the interplay?
    Sharma, P
    GUT, 2005, 54 (06) : 739 - 740
  • [26] Cardiac mucosa, Barrett's oesophagus and cancer of the gastro-oesophageal junction: what's in a name?
    Spechler, Stuart Jon
    GUT, 2017, 66 (08) : 1355 - +
  • [27] Does body mass index differ between patients with Barrett's oesophagus and patients with chronic gastro-oesophageal reflux disease?
    Gerson, L. B.
    Ullah, N.
    Fass, R.
    Green, C.
    Shetler, K.
    Singh, G.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 25 (09) : 1079 - 1086
  • [28] Oesophageal bacterial biofilm changes in gastro-oesophageal reflux disease, Barrett's and oesophageal carcinoma: association or causality?
    Blackett, K. L.
    Siddhi, S. S.
    Cleary, S.
    Steed, H.
    Miller, M. H.
    Macfarlane, S.
    Macfarlane, G. T.
    Dillon, J. F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (11) : 1084 - 1092
  • [29] MicroRNA-196a & microRNA-101 expression in Barrett's oesophagus in patients with medically and surgically treated gastro-oesophageal reflux
    Haiart S.
    Watson D.I.
    Leong M.P.
    Astill D.
    Bright T.
    Hussey D.J.
    BMC Research Notes, 4 (1)
  • [30] The role of antroduodenal dysmotility in gastro oesophageal reflux disease and Barrett's columnar lined oesophagus
    Navaratnam, RM
    Watson, A
    Winslet, MC
    GUT, 2001, 48 : A28 - A28
12345